;PMID: 9009246
;source_file_1226.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..38] = [t:0..38]
;1)sentence:[e:43..150] = [t:43..150]
;2)section:[e:154..191] = [t:154..191]
;3)section:[e:195..295] = [t:195..295]
;4)sentence:[e:299..563] = [t:299..563]
;5)sentence:[e:564..644] = [t:564..644]
;6)sentence:[e:645..724] = [t:645..724]
;7)sentence:[e:725..803] = [t:725..803]
;8)section:[e:807..851] = [t:807..851]

;section 0 Span:0..38
;Leuk Res  1996 Nov-Dec;20(11-12):901-3
(SEC
  (FRAG (VBG:[0..4] Leuk) (RB:[5..8] Res) (CD:[10..14] 1996) (IN:[15..19] Nov-)
        (CD:[19..26] Dec;20-LRB-) (CD:[26..28] 11) (::[28..29] -)
        (CD:[29..31] 12) (-RRB-:[31..32] -RRB-) (CD:[32..36] :901)
        (::[36..37] -) (CD:[37..38] 3)))

;sentence 1 Span:43..150
;RAS gene mutations in Chinese leukaemia patients and members of a family with
; high incidence of leukaemia.
;[43..46]:gene-rna:"RAS"
;[73..82]:malignancy:"leukaemia"
;[140..149]:malignancy:"leukaemia"
(SENT
  (NP-HLN
    (NP (NN:[43..46] RAS) (NN:[47..51] gene) (NNS:[52..61] mutations))
    (PP-LOC (IN:[62..64] in)
      (NP
        (NP (JJ:[65..72] Chinese) (NN:[73..82] leukaemia)
            (NNS:[83..91] patients))
        (CC:[92..95] and)
        (NP
          (NP (NNS:[96..103] members))
          (PP (IN:[104..106] of)
            (NP
              (NP (DT:[107..108] a) (NN:[109..115] family))
              (PP (IN:[116..120] with)
                (NP
                  (NP (JJ:[122..126] high) (NN:[127..136] incidence))
                  (PP (IN:[137..139] of)
                    (NP (NN:[140..149] leukaemia))))))))))
    (.:[149..150] .)))

;section 2 Span:154..191
;He LZ, Stephenson J, He GY, Mufti GJ.
(SEC
  (FRAG (NNP:[154..156] He) (NNP:[157..159] LZ) (,:[159..160] ,)
        (NNP:[161..171] Stephenson) (NNP:[172..174] J,) (NNP:[175..177] He)
        (NNP:[178..180] GY) (,:[180..181] ,) (NNP:[182..187] Mufti)
        (NNP:[188..191] GJ.)))

;section 3 Span:195..295
;Department of Haematological Medicine, King's College School of Medicine and 
;Dentistry, London, UK.
(SEC
  (FRAG (NNP:[195..205] Department) (IN:[206..208] of)
        (NNP:[209..223] Haematological) (NNP:[224..232] Medicine)
        (,:[232..233] ,) (NNP:[234..238] King) (POS:[238..240] 's)
        (NNP:[241..248] College) (NNP:[249..255] School) (IN:[256..258] of)
        (NNP:[259..267] Medicine) (CC:[268..271] and) (NNP:[273..282] Dentistry)
        (,:[282..283] ,) (NNP:[284..290] London) (,:[290..291] ,)
        (NNP:[292..295] UK.)))

;sentence 4 Span:299..563
;We investigated mutations of N-RAS and K-RAS by using polymerase chain
;reaction  (PCR)-oligonucleotide hybridization techniques in 40 cases of
;Chinese leukaemia  patients and 17 presently healthy members of a family with
;high incidence of  acute myeloid leukaemia.
;[328..333]:gene-rna:"N-RAS"
;[338..343]:gene-rna:"K-RAS"
;[353..363]:gene-protein:"polymerase"
;[450..459]:malignancy:"leukaemia"
;[539..562]:malignancy:"acute myeloid leukaemia"
(SENT
  (S
    (NP-SBJ (PRP:[299..301] We))
    (VP (VBD:[302..314] investigated)
      (NP
        (NP (NNS:[315..324] mutations))
        (PP (IN:[325..327] of)
          (NP
            (NP (NN:[328..333] N-RAS))
            (CC:[334..337] and)
            (NP (NN:[338..343] K-RAS)))))
      (PP-MNR (IN:[344..346] by)
        (S
          (NP-SBJ (-NONE-:[346..346] *))
          (VP (VBG:[347..352] using)
            (NP
              (NML
                (NML
                  (NML (NN:[353..363] polymerase) (NN:[364..369] chain)
                       (NN:[370..378] reaction))
                  (NML (-LRB-:[380..381] -LRB-) (NN:[381..384] PCR)
                       (-RRB-:[384..385] -RRB-)))
                (HYPH:[385..386] -)
                (NML (NN:[386..401] oligonucleotide)
                     (NN:[402..415] hybridization)))
              (NNS:[416..426] techniques))
            (PP (IN:[427..429] in)
              (NP
                (NP (CD:[430..432] 40) (NNS:[433..438] cases))
                (PP (IN:[439..441] of)
                  (NP
                    (NP (JJ:[442..449] Chinese) (NN:[450..459] leukaemia)
                        (NNS:[461..469] patients))
                    (CC:[470..473] and)
                    (NP
                      (NP (CD:[474..476] 17)
                        (ADJP (RB:[477..486] presently) (JJ:[487..494] healthy))
                        (NNS:[495..502] members))
                      (PP (IN:[503..505] of)
                        (NP
                          (NP (DT:[506..507] a) (NN:[508..514] family))
                          (PP (IN:[515..519] with)
                            (NP
                              (NP (JJ:[520..524] high) (NN:[525..534] incidence))
                              (PP (IN:[535..537] of)
                                (NP (JJ:[539..544] acute)
                                    (JJ:[545..552] myeloid)
                                    (NN:[553..562] leukaemia))))))))))))))))
    (.:[562..563] .)))

;sentence 5 Span:564..644
;The results showed only two patients carried the  mutation in codon 12 of
;N-RAS.
;[614..622]:variation-event:"mutation"
;[626..634]:variation-location:"codon 12"
;[638..643]:gene-rna:"N-RAS"
(SENT
  (S
    (NP-SBJ (DT:[564..567] The) (NNS:[568..575] results))
    (VP (VBD:[576..582] showed)
      (SBAR (-NONE-:[582..582] 0)
        (S
          (NP-SBJ
            (ADVP (RB:[583..587] only))
            (CD:[588..591] two) (NNS:[592..600] patients))
          (VP (VBD:[601..608] carried)
            (NP
              (NP (DT:[609..612] the) (NN:[614..622] mutation))
              (PP-LOC (IN:[623..625] in)
                (NP
                  (NP (NN:[626..631] codon) (CD:[632..634] 12))
                  (PP (IN:[635..637] of)
                    (NP (NN:[638..643] N-RAS))))))))))
    (.:[643..644] .)))

;sentence 6 Span:645..724
;Strikingly, however, in both cases the  malignancies involved lymphoid
;lineage.
;[685..697]:malignancy:"malignancies"
(SENT
  (S
    (ADVP (RB:[645..655] Strikingly))
    (,:[655..656] ,)
    (ADVP (RB:[657..664] however))
    (,:[664..665] ,)
    (PP (IN:[666..668] in)
      (NP (DT:[669..673] both) (NNS:[674..679] cases)))
    (NP-SBJ (DT:[680..683] the) (NNS:[685..697] malignancies))
    (VP (VBD:[698..706] involved)
      (NP (JJ:[707..715] lymphoid) (NN:[716..723] lineage)))
    (.:[723..724] .)))

;sentence 7 Span:725..803
;There was no hereditary RAS mutation in  the members of the remarkable
;family.
;[749..752]:gene-rna:"RAS"
(SENT
  (S
    (NP-SBJ (EX:[725..730] There))
    (VP (VBD:[731..734] was)
      (NP-PRD (DT:[735..737] no) (JJ:[738..748] hereditary) (NN:[749..752] RAS)
              (NN:[753..761] mutation))
      (PP (IN:[762..764] in)
        (NP
          (NP (DT:[766..769] the) (NNS:[770..777] members))
          (PP (IN:[778..780] of)
            (NP (DT:[781..784] the) (JJ:[785..795] remarkable)
                (NN:[796..802] family))))))
    (.:[802..803] .)))

;section 8 Span:807..851
;PMID: 9009246 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[807..811] PMID) (::[811..812] :) (CD:[813..820] 9009246)
        (NN:[821..822] -LSB-) (NNP:[822..828] PubMed) (::[829..830] -)
        (NN:[831..838] indexed) (IN:[839..842] for)
        (NNP:[843..851] MEDLINE-RSB-)))
